- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 1.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.06M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 128.36K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$252.75K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$404.62K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $7.05M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $7.15M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $5.59M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.49M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $726.9K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $743.6K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $726.9K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $743.6K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.84M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.02M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.78M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.9M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.71 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.71 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $210.24K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $182.6K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$173.77K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$476.3K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$135.81K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$334K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $374.11K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $136.86K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $370.79K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $583.44K |
| Revenue | Q1 2026 · Mar 31, 2026 | $744.9K |
| Revenue | Q1 2026 · Mar 31, 2025 | $720.3K |